#
PrabotulinumtoxinA-xvfs
  • Professionals
  • AHFS Monographs

PrabotulinumtoxinA-xvfs

Class: Other Miscellaneous Therapeutic Agents
Chemical Name: Botulin A
Molecular Formula: C6760H10447N1743O2010S32
CAS Number: 93384-43-1
Brands: Jeuveau

Medically reviewed by Drugs.com on Feb 15, 2022. Written by ASHP.

Warning

    Warning: Distant Spread Of Toxin Effect
  • See full prescribing information for complete boxed warning.

  • The effects of all botulinum toxin products, including prabotulinumtoxinA-xvfs, may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. PrabotulinumtoxinA-xvfs is not approved for the treatment of spasticity or any conditions other than glabellar lines.

Introduction

PrabotulinumtoxinA-xvfs is an acetylcholine release inhibitor and a neuromuscular blocking agent.

Uses for PrabotulinumtoxinA-xvfs

PrabotulinumtoxinA-xvfs has the following uses:

PrabotulinumtoxinA-xvfs is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.

PrabotulinumtoxinA-xvfs Dosage and Administration

General

PrabotulinumtoxinA-xvfs is available in the following dosage form(s) and strength(s):

For Injection: 100 units vacuum-dried powder in a single-dose vial for reconstitution.

Dosage

It isessentialthat the manufacturer's labeling be consulted for more detailed information on dosage and administration of this drug. Dosage summary:

Adults

Dosage and Administration

0.1 mL (4 units) prabotulinumtoxinA-xvfs by intramuscular injection into each of five sites, for a total dose of 20 units.

When used for retreatment, prabo..